Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Operating Leases (2020 - 2024)

Pharma-Bio Serv (PBSV) has disclosed Operating Leases for 5 consecutive years, with $28834.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Operating Leases fell 85.14% year-over-year to $28834.0, compared with a TTM value of $28834.0 through Oct 2024, down 85.14%, and an annual FY2024 reading of $28834.0, down 85.14% over the prior year.
  • Operating Leases was $28834.0 for Q4 2024 at Pharma-Bio Serv, down from $71362.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $729389.0 in Q1 2020 and bottomed at $28834.0 in Q4 2024.
  • Average Operating Leases over 5 years is $393144.6, with a median of $400460.0 recorded in 2022.
  • The sharpest move saw Operating Leases dropped 18.42% in 2021, then plummeted 85.14% in 2024.
  • Year by year, Operating Leases stood at $629979.0 in 2020, then fell by 22.64% to $487364.0 in 2021, then decreased by 28.9% to $346509.0 in 2022, then crashed by 44.0% to $194035.0 in 2023, then tumbled by 85.14% to $28834.0 in 2024.
  • Business Quant data shows Operating Leases for PBSV at $28834.0 in Q4 2024, $71362.0 in Q3 2024, and $113044.0 in Q2 2024.